Hemodialysis-based interventions to preserve cognitive function
以血液透析为基础的干预措施以保留认知功能
基本信息
- 批准号:10320432
- 负责人:
- 金额:$ 6.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-01-09 至 2022-02-14
- 项目状态:已结题
- 来源:
- 关键词:AdultAnxietyCessation of lifeCharacteristicsClinicalCognitionCommunitiesCountryDialysis procedureDigit structureEducational InterventionElderlyEnd stage renal failureEnrollmentEthnic OriginFatigueFrequenciesGeneral PopulationGerontologyHemodialysisHospitalizationHourHypotensionImpairmentIntentionInterventionKidney DiseasesLearningLifeMeasuresMental DepressionModalityNephrologyOutcomePain interferencePatient Self-ReportPatient-Focused OutcomesPatientsPhysical FunctionProviderQuality of lifeRaceRandomizedRandomized Controlled TrialsRenal dialysisReportingRestRoleSleepSleep disturbancesTestingTimeTrail Making TestTransplantationadverse outcomebasecognitive functioncognitive testingcognitive trainingdisabilityeffective interventionexecutive functionexercise trainingexperiencefallsfeasibility testingfeasibility trialfunctional declineimprovedinsightinterestmental statemortalitypreservationpreventprimary outcomesecondary outcomesexstandard of caretv watching
项目摘要
ABSTRACT
Over 640,000 US adults suffer from ESRD, >95% of whom receive hemodialysis (HD) for the rest of their life or
until transplantation. Kidney disease and HD significantly impact cognitive function, especially higher-order
executive function. Only 13% of HD patients have normal cognition; HD patients experience executive function
impairment at a rate 3-fold higher than the general population, leading to hospitalization, disability, and death.
Studies of older adults suggest that the only effective interventions for preserving executive function are
cognitive training (CT) and/or exercise training (ET). These modalities have not been tested for executive
function preservation in HD patients; even younger HD patients suffer substantial executive function
impairment and could benefit from these interventions. HD frequency (3 sessions a week) and duration (4-6
hours/session) makes HD patients a “captive audience” for intradialytic CT and/or ET to mitigate executive
function decline. In preliminary studies, HD patients reported spending most of their time watching TV;
intradialytic CT and/or ET could replace these passive activities. In preliminary studies, 87% of nephrology
providers believed that their patients would be interested in intradialytic CT and 83% believed that their
patients would be interested in intradialytic ET. Among HD patients, 67% wanted to improve their cognition
through CT and 71% wanted to improve their strength and cognition through ET while undergoing HD.
To test the feasibility of intradialytic interventions, we conducted a pilot RCT of 20 HD patients, comparing
standard of care to CT or ET; even in this pilot, we found that intradialytic CT and ET preserved executive
function. As expected, executive function in patients receiving standard of care declined substantially by 3
months (difference=47.4 seconds, P=0.006); however, this decline was not seen among those receiving CT or
ET. Compared with standard of care, the difference in mean change was -46.72 seconds (95% CI: -91.12, -
2.31; P=0.04) for CT and -56.21 seconds (95% CI: -105.86, -6.56; P=0.03) for ET. In just 3 months, CT and ET
preserved executive function compared to a striking decline with standard of care.
To properly test the impact of intradialytic CT and/or ET, on the executive function decline associated with HD,
we propose the following aims: 1) To conduct an RCT to evaluate executive function decline in the setting of
intradialytic CT and/or ET, 2) To quantify the effects of intradialytic CT and/or ET on ESRD-specific clinical
outcomes, 3) To quantify the effects of intradialytic CT and/or ET, on patient-centered outcomes.
Through this RCT, we will learn the impact of two potential non-pharmacological interventions, cognitive and
exercise training, in preserving executive function during HD. If successful, this will improve HD outcomes of
>640,000 adults with ESRD. For the first time, we will have validated, beneficial activities replace the typical
passive activities of HD patients. Our findings will be implementable in dialysis centers across the country to
help reduce the decline in executive function.
抽象的
超过64万名美国成年人患有ESRD,> 95%的人一生都接受血液透析(HD)或
直到移植。肾脏疾病和HD显着影响认知功能,尤其是高阶
执行功能。只有13%的HD患者患有正常的认知;高清患者经历执行功能
损害比一般人群高3倍,导致住院,残疾和死亡。
对老年人的研究表明,保存执行功能的唯一有效干预措施是
认知训练(CT)和/或运动培训(ET)。这些方式尚未测试过高管
高清患者的功能保留;即使是年轻的高清患者,执行功能也很大
损害,可以从这些干预措施中受益。高清频率(每周3次)和持续时间(4-6
小时/会议)使高清患者成为乳中CT和/或ET的“圈养受众”,以减轻高管
功能下降。在初步研究中,高清患者报告大部分时间看电视。
子宫内CT和/或ET可以取代这些被动活动。在初步研究中,有87%的肾脏病
提供者认为他们的患者对同烯性CT和83%的患者有兴趣。
患者将对归酯内的ET感兴趣。在高清患者中,有67%的患者想改善其认知
通过CT和71%的人希望通过ET进行高清时通过ET提高其强度和认知。
为了测试酯内干预措施的可行性,我们进行了20个HD患者的试验RCT,进行了比较
CT或ET的护理标准;即使在这个飞行员中,我们也发现莱准内部的CT和ET保留了执行
功能。正如预期的那样,接受护理标准的患者的执行功能大大下降了3
月份(差异= 47.4秒,p = 0.006);但是,在接收CT或
等。与护理标准相比,平均变化的差异为-46.72秒(95%CI:-91.12, -
2.31; CT和-56.21秒(95%CI:-105.86,-6.56; P = 0.03)的P = 0.04)。在短短三个月内,CT和ET
与护理标准的罢工下降相比,保留的执行功能相比。
为了正确测试同烯性CT和/或ET的影响,对与HD相关的执行功能下降,
我们提出以下目的:1)进行RCT,以评估执行功能的下降
鉴别内CT和/或ET,2)量化子宫内CT和/或ET对ESRD特异性临床的影响
结局,3)量化酯内CT和/或ET的影响对以患者为中心的结果。
通过此RCT,我们将学习两种潜在的非药理学干预措施的影响,即认知和
锻炼训练,在高清期间保存执行功能方面。如果成功,这将改善
ESRD> 640,000名成年人。我们将第一次验证,有益的活动取代典型的活动
高清患者的被动活动。我们的发现将在全国各地的透析中心实施
帮助减少执行功能的下降。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mara A. McAdams DeMarco其他文献
Abdominal CT measurements of body composition and waitlist mortality in kidney transplant candidates.
腹部 CT 测量肾移植候选者的身体成分和候补死亡率。
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:8.8
- 作者:
Evelien E. Quint;Yi Liu;O. Shafaat;Nidhi Ghildayal;Helen Crosby;A. Kamireddy;Robert A. Pol;B. Orandi;Dorry L. Segev;Clifford R. Weiss;Mara A. McAdams DeMarco - 通讯作者:
Mara A. McAdams DeMarco
Recipient Age and Time Spent Hospitalized in the Year Before and After Kidney Transplantation
肾移植前后一年受者年龄和住院时间
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:6.2
- 作者:
M. Grams;Mara A. McAdams DeMarco;L. Kucirka;D. Segev - 通讯作者:
D. Segev
Mara A. McAdams DeMarco的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mara A. McAdams DeMarco', 18)}}的其他基金
Cognitive prehabilitation to prevent Alzheimer's disease after kidney transplantation
认知预康复预防肾移植后阿尔茨海默病
- 批准号:
10557957 - 财政年份:2022
- 资助金额:
$ 6.02万 - 项目类别:
Impact of climate change on cognitive and physical aging of older kidney transplant recipients
气候变化对老年肾移植受者认知和身体衰老的影响
- 批准号:
10838643 - 财政年份:2022
- 资助金额:
$ 6.02万 - 项目类别:
Structural Racism, Resilience, and Premature Cognitive Aging in End-stage Renal Disease
终末期肾病中的结构性种族主义、复原力和过早认知衰老
- 批准号:
10471530 - 财政年份:2022
- 资助金额:
$ 6.02万 - 项目类别:
Structural Racism, Resilience, and Premature Cognitive Aging in End-stage Renal Disease
终末期肾病中的结构性种族主义、复原力和过早认知衰老
- 批准号:
10659198 - 财政年份:2022
- 资助金额:
$ 6.02万 - 项目类别:
Hemodialysis-based interventions to preserve cognitive function
以血液透析为基础的干预措施以保留认知功能
- 批准号:
10600287 - 财政年份:2018
- 资助金额:
$ 6.02万 - 项目类别:
Developing personalized immunosuppression for older kidney transplant recipients
为老年肾移植受者开发个性化免疫抑制
- 批准号:
10598964 - 财政年份:2018
- 资助金额:
$ 6.02万 - 项目类别:
Alzheimer's Supplement to Hemodialysis-based interventions to preserve cognitive function
阿尔茨海默病补充血液透析干预措施以保持认知功能
- 批准号:
10286431 - 财政年份:2018
- 资助金额:
$ 6.02万 - 项目类别:
Developing personalized immunosuppression for older kidney transplant recipients
为老年肾移植受者开发个性化免疫抑制
- 批准号:
10304934 - 财政年份:2018
- 资助金额:
$ 6.02万 - 项目类别:
Developing personalized immunosuppression for older kidney transplant recipients
为老年肾移植受者开发个性化免疫抑制
- 批准号:
10063523 - 财政年份:2018
- 资助金额:
$ 6.02万 - 项目类别:
Alzheimer's Supplement to ESRD-specific physiologic age
阿尔茨海默病对 ESRD 特定生理年龄的补充
- 批准号:
10286420 - 财政年份:2017
- 资助金额:
$ 6.02万 - 项目类别:
相似国自然基金
电针激活大麻素CB1受体抑制mPFC–LS环路缓解应激性焦虑的机制
- 批准号:82374584
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
电针抑制AdipoR1蛋白磷酸化调控VTA相关环路功能改善焦虑症恐惧记忆障碍的机制研究
- 批准号:82374254
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
下丘脑室旁核精氨酸加压素神经元亚群调控焦虑行为的机制
- 批准号:32371068
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
m6A识别蛋白YTHDF3调控焦虑样行为的作用和分子机制研究
- 批准号:82301701
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
腹侧海马星形胶质细胞参与焦虑症发病的机制研究
- 批准号:82371513
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Computational and neural signatures of interoceptive learning in anorexia nervosa
神经性厌食症内感受学习的计算和神经特征
- 批准号:
10824044 - 财政年份:2024
- 资助金额:
$ 6.02万 - 项目类别:
Opioid Use and Acute Suicide Risk: The Real-Time Influence of Trauma Context"
阿片类药物的使用和急性自杀风险:创伤背景的实时影响”
- 批准号:
10674342 - 财政年份:2023
- 资助金额:
$ 6.02万 - 项目类别:
Evaluating the Effects of Animal Therapy on Anxiety in Pediatric Dental Patients
评估动物疗法对小儿牙科患者焦虑的影响
- 批准号:
10649010 - 财政年份:2023
- 资助金额:
$ 6.02万 - 项目类别:
Using Patients' Stated Preferences to Inform and Support Proxy Decision-making during Palliative Treatment: Instrument Development and Evaluation
在姑息治疗期间利用患者陈述的偏好来告知和支持代理决策:仪器开发和评估
- 批准号:
10819002 - 财政年份:2023
- 资助金额:
$ 6.02万 - 项目类别:
Efficacy and implementation of exercise-based smoking cessation treatment for adults with high anxiety sensitivity
以运动为基础的戒烟治疗对高焦虑敏感性成人的疗效和实施
- 批准号:
10660767 - 财政年份:2023
- 资助金额:
$ 6.02万 - 项目类别: